Literature DB >> 16299782

Diagnostic and therapeutic endoscopy.

E J Kuipers1, J Haringsma.   

Abstract

Within the gastrointestinal tract, there is no shorter segment with a higher cancer incidence than the gastro-esophageal junction. Flexible endoscopy is the mainstay for diagnosis of early and advanced esophageal adenocarcinoma, for the treatment of early lesions, and also for the palliation of advanced cancer. New developments in endoscopy aim to improve the diagnosis and treatment of esophageal cancer. These include high resolution and magnification endoscopy in combination with chromendoscopy, and techniques based on modulation of the features of light bundles, such as narrow band imaging, fluorescence endoscopy, and elastic scattering spectroscopy. The value of these techniques for the surveillance of distal esophageal neoplasia needs further study. Furthermore, new methods of tissue sampling and evaluation are being studied to augment identification and staging of patients at risk for cancer. Finally, newer instruments may decrease patient burden during endoscopy, making screening and surveillance more acceptable from a patient's perspective. This review discusses the new developments in flexible endoscopy for diagnosis and therapy of early and advanced and advanced esophageal adenocarcinoma. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16299782     DOI: 10.1002/jso.20361

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Are we making progress in diagnosing and preventing gastrointestinal cancers?

Authors:  Jelle Haringsma; Nicoline C M van Heel; Ernst J Kuipers
Journal:  Therap Adv Gastroenterol       Date:  2010-07       Impact factor: 4.409

Review 2.  The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment.

Authors:  Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

3.  Affinity peptide developed by phage display selection for targeting gastric cancer.

Authors:  Wen-Jie Zhang; Yan-Xia Sui; Arun Budha; Jian-Bao Zheng; Xue-Jun Sun; Ying-Chun Hou; Thomas D Wang; Shao-Ying Lu
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

4.  Risk of multiple early gastric cancers in a patient with precursor lesions and endoscopic surveillance for 7 years: A case report.

Authors:  Hui Pan; Chaoying Fang; Liping He; Houqiang Li; Lanzai Liu; Chao Wang; Jiansu Chen
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 5.  Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer.

Authors:  Yu-Jer Hsiao; Yuan-Chih Wen; Wei-Yi Lai; Yi-Ying Lin; Yi-Ping Yang; Yueh Chien; Aliaksandr A Yarmishyn; De-Kuang Hwang; Tai-Chi Lin; Yun-Chia Chang; Ting-Yi Lin; Kao-Jung Chang; Shih-Hwa Chiou; Ying-Chun Jheng
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

6.  Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.

Authors:  Bo Tang; Zhexu Li; Dingde Huang; Lei Zheng; Qianwei Li
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 7.  Advances and new technologies in adult endoscopy: can they be adapted to pediatrics?

Authors:  Joseph M Croffie
Journal:  Curr Gastroenterol Rep       Date:  2007-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.